e-learning
resources
Munich 2006
Monday 04.09.2006
Pulmonary embolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of long-term survival of patients diagnosed of pulmonary embolism (PE)
J. P. J. Luis, G. A. J. Domingo, D. P. Antonio, C. D. Aurelio, O. C. Remedios, R. P. A. Jose, E. Teresa, M. W. Ana (Seville, Spain)
Source:
Annual Congress 2006 - Pulmonary embolism
Session:
Pulmonary embolism
Session type:
Oral Presentation
Number:
2188
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. P. J. Luis, G. A. J. Domingo, D. P. Antonio, C. D. Aurelio, O. C. Remedios, R. P. A. Jose, E. Teresa, M. W. Ana (Seville, Spain). Analysis of long-term survival of patients diagnosed of pulmonary embolism (PE). Eur Respir J 2006; 28: Suppl. 50, 2188
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Diagnosis and treatment of chronic pulmonary embolism
Related content which might interest you:
Recurrence and bleeding in the extended treatment of patients with pulmonary embolism (PE) and cancer
Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism
Year: 2018
Prognostic value of the ECG on admission in patients with acute major pulmonary embolism
Source: Eur Respir J 2005; 25: 843-848
Year: 2005
The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism
Source: Eur Respir J 2011; 37: 762-766
Year: 2011
A risk score of adverse short-term clinical outcomes in patients with acute pulmonary embolism (PE)
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005
Short-term mortality in patients with acute symptomatic pulmonary embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)?
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Internal validation of a model to predict the risk of short-term (10 days) adverse outcomes in patients with pulmonary embolism (PE)
Source: Annual Congress 2006 - Pulmonary embolism
Year: 2006
Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up.
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
1 year clinical follow-up of patients affected by acute pulmonary embolism (PE)
Source: Eur Respir J 2005; 26: Suppl. 49, 270s
Year: 2005
Factors related with complications in patients with pulmonary embolism
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005
Incidental lung malignancies detected by CTPA in patients with suspected pulmonary embolism are not associated with better survival outcomes
Source: Annual Congress 2010 - Vascular and solitary lesions
Year: 2010
A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development
Source: Eur Respir J 2003; 22: Suppl. 45, 221s
Year: 2003
The analysis of pulmonary tromboembolism (PTE) in structure of mortality of therapeutic and surgical patients
Source: Eur Respir J 2007; 30: Suppl. 51, 603s
Year: 2007
Risk factors and clinical significance of residual perfusion defects after symptomatic pulmonary embolism (PE)
Source: Annual Congress 2007 - Acute and chronic pulmonary embolism
Year: 2007
Postoperative morbidity and mortality after pneumonectomy (PE) in pulmonary tuberculosis (TB) patients: a 5-year experience
Source: International Congress 2019 – Thoracic surgery
Year: 2019
Predicting short-term mortality in patients with pulmonary embolism: A simple model
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Clinical characteristics and outcomes of patients with clinically unsuspected pulmonary embolism versus patients with clinically suspected pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012
Clinical in-hospital mortality profile of pulmonary embolism
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020
Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF)
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept